Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| PFE | Pfizer Inc. | -0.36% | 33.33 | 0.9% | $1128.80m | |
| JNJ | Johnson & Johnson | -0.59% | 142.42 | 0.7% | $1055.48m | |
| BMY | Bristol-Myers Squibb Co. | -0.02% | 58.11 | 1.0% | $945.55m | |
| MRK | Merck & Co., Inc. | -0.91% | 76.00 | 0.6% | $793.75m | |
| ABBV | AbbVie, Inc. | -1.29% | 98.00 | 1.9% | $757.48m | |
| LLY | Eli Lilly & Co. | -1.60% | 166.42 | 1.1% | $674.43m | |
| AZN | AstraZeneca Plc | 0.80% | 54.41 | 1.2% | $289.75m | |
| RPRX | Royalty Pharma Plc | 0.71% | 48.36 | 0.1% | $217.04m | |
| NVS | Novartis AG | -0.86% | 87.36 | 0.2% | $145.69m | |
| RGEN | Repligen Corp. | 2.71% | 128.67 | 7.1% | $119.15m | |
| GSK | GlaxoSmithKline Plc | -0.96% | 40.34 | 0.2% | $111.05m | |
| NVO | Novo Nordisk A/S | -0.43% | 65.60 | 0.1% | $93.32m | |
| RETA | Reata Pharmaceuticals, Inc. | -1.19% | 156.12 | 3.4% | $80.52m | |
| BHVN | Biohaven Pharmaceutical Holding Co. Ltd. | -2.71% | 75.84 | 0.0% | $71.05m | |
| SNY | Sanofi | -0.14% | 50.48 | 0.2% | $68.16m |
Company Profile
Horizon Pharmaceutical LLC engages in the development of transformative treatments for people affected by rare and debilitating diseases. It offers PROCYSBI, a delayed-release capsule, which is used for the management of nephropathic cystinosis in adults and for six years and older children. The company was founded by Christopher M. Starr and Todd C. Zankel on April 29, 2002 and is headquartered in Novato, CA.